Navigation Links
ISPE Conference to Benchmark and Advance Quality by Design in the Biopharmaceutical Industry
Date:3/7/2013

TAMPA, Fla., March 7, 2013 /PRNewswire/ -- ISPE announced today that it will hold its first-ever conference focused on benchmarking and advancing the development of Quality by Design (QbD) in the biopharmaceutical industry. The two-day event, taking place 10 – 11 April 2013 in San Francisco, Calif. USA, will feature workshops and discussions on the industry's progress since the introduction of A-Mab and steps for further adoption of QbD principles. The conference is endorsed by CASSS, a not-for-profit 501(c)(6) professional scientific society made up of over 4,000 industry, academic and public sector professionals.

"Quality by Design is a critical issue for the industry, with companies and global regulatory authorities working to help the industry adopt QbD practices," said Nancy Berg , ISPE President and CEO. "As the global pharmaceutical association representing the entire pharmaceutical lifecycle, ISPE will bring together top QbD experts to discuss how planning and controlling product evolution can lead to superior quality, better resource use and increased business effectiveness."

The State of Quality by Design in the Biopharmaceutical Industry Conference will offer in-depth case studies, lessons learned and best practices in implementing QbD. Pfizer's Roger Nosal , Vice President, Global Chemistry, Manufacturing and Controls (GCMC), will present a plenary address titled "Carpe Opportunite: Regulatory Experience with Implementation of QbD, An Industry Perspective." Mr. Nosal has an extensive history of leading advanced technology dialog among industry and regulators.

Speakers and delegates from Abbott, Amgen, Eli Lilly, Genentech, MedImmune, Merck, Pfizer, Roche and more will explore challenges and solutions with industr
'/>"/>

SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
6. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
7. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
8. PRA Expert to Present at Pharmacovigilance Conference
9. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
10. Verenium to Present at Baird Clean Technology Conference
11. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014 Research and Markets ... Size Analysis Market 2014-2018" report to their offering. ... size analysis is a technique used to determine the size ... liquid. It is crucial to analyze the size of particles ... particle size analysis is performed to determine the behavior and ...
(Date:7/26/2014)... Canada Endoscopy Visualization Systems Market ... the Canada Endoscopy Visualization Systems market. The report ... (in units) and average prices (in US dollars) ... Mid-Range Endoscopy Visualization Systems and Low-End Endoscopy Visualization ... . , The report also provides company shares ...
(Date:7/25/2014)... , July 25, 2014 Amgen (NASDAQ: ... today declared a $0.61 per share dividend for the ... on Sept. 5, 2014, to all stockholders of record ... 2014.  About Amgen Amgen is committed ... from serious illnesses by discovering, developing, manufacturing and delivering ...
(Date:7/25/2014)... from the University of Leicester has furthered our ... potential to create new materials using nanosized ,building ... in the prestigious academic journal Physical Review ... examine in rich detail the structure and internal ... acetylene molecule and a single helium atom. , ...
Breaking Biology Technology:Global Particle Size Analysis Market 2014-2018 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3
... revenue increase as broad corporate changes are ... ... Nanotech, Inc. (OTC,Bulletin Board: AVNA) today reported financial results for its ... fiscal,period since the Company refocused its business model from managing the,development ...
... 16 Immunosyn,Corporation (OTC Bulletin Board: IMYN), a ... and distribution rights to,the biopharmaceutical SF-1019 from its ... the quarter ending March 31, 2008., For ... incurred $175,632.00,in general and administrative expenses and $13,393.00 ...
... in the ... ... BSX ) today announced U.S. Food and Drug Administration,(FDA) approval of ... defibrillators (CRT-D) and cardiac,resynchronization therapy pacemakers (CRT-P), both of which treat ...
Cached Biology Technology:Advance Nanotech Reports First Quarter 2008 Financial Results 2Advance Nanotech Reports First Quarter 2008 Financial Results 3Advance Nanotech Reports First Quarter 2008 Financial Results 4Advance Nanotech Reports First Quarter 2008 Financial Results 5Advance Nanotech Reports First Quarter 2008 Financial Results 6Advance Nanotech Reports First Quarter 2008 Financial Results 7Advance Nanotech Reports First Quarter 2008 Financial Results 8Advance Nanotech Reports First Quarter 2008 Financial Results 9Advance Nanotech Reports First Quarter 2008 Financial Results 10Immunosyn Corporation Files 10-Q 2Immunosyn Corporation Files 10-Q 3Boston Scientific Announces FDA Approval of New Heart Failure Lead 2Boston Scientific Announces FDA Approval of New Heart Failure Lead 3Boston Scientific Announces FDA Approval of New Heart Failure Lead 4
(Date:7/27/2014)... date, researchers from the U.K. provide national, regional, and ... (HCV). Findings published in Hepatology, a journal of the ... that genotype 1 is the most prevalent worldwide, with ... in East Asia. Genotype 3, at just over 54 ... genotypes 2, 4, 6, and 5. , Despite ...
(Date:7/27/2014)... Microorganisms like bacteria and fungi can evade treatment by ... antifungal drugs. These permanent mutations were once thought to ... Now a new study has shown that microorganisms can ... as epimutations -- to gain the benefits of drug ... was discovered in a fungus called Mucor circinelloides, it ...
(Date:7/27/2014)... scientists at Barts Cancer Institute have found that targeting ... significantly more effective, according to research published in ... Institute, part of Queen Mary University of London, have ... signals the body to repair itself after chemotherapy or ... the researchers removed FAK from blood vessels that grew ...
Breaking Biology News(10 mins):Hepatitis C virus genotype 1 is most prevalent worldwide 2Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3New drug target can break down cancer's barrier against treatment 2
... threat, city and country birds do not react in the ... a new study, urban birds have changed their anti-predator behaviour ... with a predator, its only objective is to escape. However, ... their countryside counterparts, despite being from the same species. Urbanisation ...
... backbone of our modern economy. Nearly every aspect of life ... it is not just the lights that go out. In ... working. Even telephones, radios and televisions become paralyzed. If the ... gas and fuel and the functioning of respirators at intensive ...
... advances in the new and developing field of restoration ... deltas from an array of threats, Indiana University Bloomington ... Nature Geoscience . The commentary, published this week ... is disappearing from river deltas at alarming rates. And ...
Cached Biology News:City birds adapt to their new predators 2Dealing with power outages more efficiently 2Geologist calls for advances in restoration sedimentology 2
... active ingredient in Molecular Probes. SlowFadeAntifade ... to act as a free radical ... Our original SlowFade formulation (S-2828) was ... of fluorescein to almost zero (Figure ...
b6-2A12...
... in this kit are prepared with pure ... Biochains Mitochondria Isolation Kit is designed to ... fast and easy way. One kit is ... isolations (enriching mitochondria from 10 20 ...
... The Freedom EVOlyzer is Tecans new ... automated microplate processing. Freedom EVOlyzer is a ... includes state-of-the art reader, washer and incubation ... software. The Freedom EVOlyzer is available in ...
Biology Products: